Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1072461

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1072461

Global Opioids Market Size, Share & Industry Trends Analysis Report By Application (Pain Management, Cough Treatment and Diarrhea Treatment), By Product Type, By Regional Outlook and Forecast, 2021 - 2027

PUBLISHED:
PAGES: 180 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3600
PDF (Site License)
USD 4320
PDF (Enterprisewide License)
USD 6048

Add to Cart

The Global Opioids Market size is expected to reach $5.4 billion by 2027, rising at a market growth of 3.5% CAGR during the forecast period.

Opioids essentially serve as pain relievers since they are composed of substances that relax muscles and alleviate pain and stress. Prescription opioids are mostly used to treat moderate to severe pain, while some opioids can be used to treat cough and diarrhea. Hydrocodone, oxycodone, codeine, fentanyl, methadone, morphine, and other prescription opioids are among them. Opioids are the most commonly prescribed pain relievers for people suffering from moderate to severe chronic pain. Individuals diagnosed with terminal illnesses suffering from severe and chronic physical pain are the main recipient of these analgesics.

Due to an increase in demand for optimal products for treating various ailments, the opioids market is predicted to grow significantly throughout the forecast period. Increased usage of these pharmaceuticals to battle pain, as well as an increase in the senior population, which is more prone to orthopedic pain, are two significant reasons driving the market's expansion. Furthermore, rising disposable income in developing economies like India, China, and others contributes to market expansion. Prescription opioids, which include oxycodone, hydrocodone, and morphine, among others, are powerful pain relievers with both positive and negative side effects.

According to the National Institutes of Health, opioids are commonly used to treat adults suffering from moderate to severe pain, while some opioids can also be used to treat cough and diarrhea. Since a few years, there has been an increase in the demand for opioids, which are used to treat pain. Increasing demand for opioids has been seen across areas as a result of increased knowledge of palliative care and favorable reimbursement policies, as well as the implementation of Opioids Maintenance Treatment (OMT).

Extended opioid options to users in terms of effectiveness and convenience, as well as regulatory support, will create opportunities. Additionally, corporations are raising awareness of palliative care options in addition to painkillers. For top opioid firms, developing commercial and prospective formulations with enhanced efficiency and potency versions is projected to give potential opportunities. Fujian Cancer Hospital, for example, continued its Phase III clinical trial research of the fentanyl patch in September 2020 to investigate its safety and efficacy in opioid-naive patients with moderate cancer pain.

COVID-19 Impact

The outbreak of the COVID-19 pandemic has impacted every domain of the business sector. The disease quickly spread across the globe after its discovery in Wuhan. Furthermore, this virus causes a variety of symptoms in individuals, ranging from minor to severe. Fever, dry cough, and exhaustion are some of the most prevalent symptoms. Some of the most severe and alarming symptoms observed in COVID-19 patients are shortness of breath, chest pain and a progressive decline in speech and movement. Additionally, the virus has a significant fatality potential in the elderly population. Also, only a few handpicked vaccines have gained approval for preventive purposes.

Market Growth Factors

High incidence of chronic pain in adults

Globally, physical pain is a major issue. According to estimates by NCBI5, 20% of adults worldwide suffer from some kind of physical pain, with 10% of those get newly diagnosed with chronic pain each year. Nonetheless, the problem of pain has been predominantly viewed as a medical issue, with little attention paid to it by the field of public health. Pain's ubiquity, incidence, and wide-ranging social and health repercussions necessitate that the public health community pay close attention to it. As a result, health care practitioners and public health professionals will have a better understanding of pain, as well as the best public health and social policy approaches to the problem.

Demand for Strong Agonists

An agonist is a pharmacological molecule that activates specific brain receptors. When only a small number of receptors are engaged, this agonist elicits a strong physiological/pharmacological response, indicating that the medication has high intrinsic activity. Fentanyl, morphine, dihydromorphinone, meperidine, oxycodone, and oxymorphone are all strong agonist opioids. COVID-19 wreaked havoc on the global health system. During the COVID-19 pandemic, health organizations around the world were focused on preventing infection and treating COVID-19 patients, which resulted in the cancellation of elective procedures and consultations, which had an impact on pain services provided by hospitals and pain clinics

Market Restraining Factors

Increasing Cases of Opioid Addictions and Overdoses

The CDC continues to track opioid overdose deaths because the prevalence of drug overdose deaths involving opioids remains high. In 2019, opioids were responsible for almost 50,000 deaths, more than six times the amount of opioid-related overdose deaths in 1999. It's critical to figure out and classify which drugs are involved in an overdose, how frequently they're involved, and how their involvement evolves over time. We can better identify effective preventative and response efforts by identifying drug involvement. Historically, the National Vital Statistics System mortality data (NVSS-M) was utilized to analyze overdose death data, with the combined categories of natural, semi-synthetic, and synthetic opioids (including methadone) being used to report on overdose deaths involving prescription opioids.

Application Outlook

Based on Application, the market is segmented into Pain Management, Cough Treatment and Diarrhea Treatment. The cough segment observed a significant revenue share in the opioids market in 2020. Opioids are the only demonstrably effective centrally active anti-tussive medicines, and they are considered to work by suppressing mu and kappa opioid receptors in the brainstem cough region. They're the first-line symptomatic treatment for a bad cough.

Product Type Outlook

Based on Product Type, the market is segmented into Methadone, Oxycodone, Hydrocodone, Fentanyl, Codeine, Morphine and Others. The methadone segment acquired the largest revenue share in the opioids market in 2020. Methadone is a manmade, long-acting opioid that has pharmacologic properties that are qualitatively similar to morphine and can be administered orally or intravenously. It is predominantly an agonist for the μ-receptor, and it may imitate natural opioids, enkephalins, and endorphins, as well as alter the release of other neurotransmitters such as acetylcholine, norepinephrine, substance P, and dopamine. 3 Its pain relief and antitussive properties, as well as respiratory depression, sedation, decreased bowel motility, increased biliary tone, hormone regulation, including increased prolactin and growth hormone release, miotic pupils, nausea, and hypotension, are all due to this. The demand for methadone is expected to grow in the future due to increased methadone adoption internationally.

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. North America accounted for the largest revenue share in the opioids market in 2020. Due to the strong infrastructure for developmental research, the availability of substantial research funds, and the surge in the number of surgeries, research efforts for opioids medications in the treatment of cancer pain are on the rise in this region.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Endo International PLC, Mallinckrodt PLC, Sanofi S.A., Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., and Purdue Pharma L.P.

Strategies deployed in Opioids Market

Dec-2021: Teva Pharmaceuticals released Narcan 1, naloxone hydrochloride nasal spray, in the United States. The nasal spray is used to cure an opioid emergency such as an overdose or opioid overdose with symptoms of severe sleepiness and breathing problems or not in a state to respond.

Dec-2021: Boehringer Ingelheim received FDA approval along with acceptance of a biologics license application for spesolimab in treating generalized pustular psoriasis flares. According to the approval, the drug regulatory agency allowed orphan drug appointments to spesolimab for GPP treatment, and advance therapy designation to treat GPP flares in adults.

Nov-2021: Sanofi completed the acquisition of Kadmon Holdings, a biopharmaceutical company that discovers, develops, and markets transformative therapies for unmet medical needs. This acquisition aimed to bolster the expansion and growth of the General Medicines offerings. In addition, this acquisition would support Sanofi's strategy to continuously grow its General Medicines core assets that would immediately join Rezurock to its transplant suite.

May-2021: Teva Pharmaceuticals introduced Teva, the first available generic version of HIOLA tablets. The drug provides a common version of THIOLA tablets for the precaution of kidney stones as well as unresponsive treatment with diet modification, high fluid intake, and alkali.

Apr-2021: Teva Pharmaceuticals released the generic version of Absorica 1 capsules. The drug includes 10 mg, 20 mg, 25 mg, 30 mg, 35 mg, and 40 mg strength capsules for the treatment of severe recalcitrant nodular acne in non-pregnant patients 12 years of age and older as well as who are irresponsible to treat acne therapy, including antibiotics.

Mar-2020: Pfizer along with Eli Lilly announced the acceptance for review of a Biologics License Application by FDA for tanezumab 2.5 mg administered subcutaneously. The drug is developed for patients suffering from chronic pain caused due to moderate-to-severe osteoarthritis, who have faced insufficient pain relief with other analgesics. Moreover, new innovations are required for the treatment of osteoarthritis, as there is no new medicine batch for exhausting situations.

Jan-2017: Teva Pharmaceutical received FDA approval for VANTRELATM ER extended-release tablets formulated with Teva's proprietary abuse deterrence technology. The approval of VANTRELA ER is demonstrated for the management of extreme pain sufficient to require daily, around-the-clock, long-term opioid treatment and for substitute treatment options are deficient.

Scope of the Study

Market Segments covered in the Report:

By Application

  • Pain Management
  • Cough Treatment and
  • Diarrhea Treatment

By Product Type

  • Methadone
  • Oxycodone
  • Hydrocodone
  • Fentanyl
  • Codeine
  • Morphine and
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Johnson & Johnson
  • AstraZeneca PLC
  • Boehringer Ingelheim International GmbH
  • Endo International PLC
  • Mallinckrodt PLC
  • Sanofi S.A.
  • Pfizer, Inc.
  • Teva Pharmaceuticals Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Purdue Pharma L.P.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Opioids Market, by Application
    • 1.4.2 Global Opioids Market, by Product Type
    • 1.4.3 Global Opioids Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Opioids Market by Application

  • 3.1 Global Pain Management Market by Region
  • 3.2 Global Cough Treatment Market by Region
  • 3.3 Global Diarrhea Treatment Market by Region

Chapter 4. Global Opioids Market by Product Type

  • 4.1 Global Methadone Market by Region
  • 4.2 Global Oxycodone Market by Region
  • 4.3 Global Hydrocodone Market by Region
  • 4.4 Global Fentanyl Market by Region
  • 4.5 Global Codeine Market by Region
  • 4.6 Global Morphine Market by Region
  • 4.7 Global Other Product Type Market by Region

Chapter 5. Global Opioids Market by Region

  • 5.1 North America Opioids Market
    • 5.1.1 North America Opioids Market by Application
      • 5.1.1.1 North America Pain Management Market by Country
      • 5.1.1.2 North America Cough Treatment Market by Country
      • 5.1.1.3 North America Diarrhea Treatment Market by Country
    • 5.1.2 North America Opioids Market by Product Type
      • 5.1.2.1 North America Methadone Market by Country
      • 5.1.2.2 North America Oxycodone Market by Country
      • 5.1.2.3 North America Hydrocodone Market by Country
      • 5.1.2.4 North America Fentanyl Market by Country
      • 5.1.2.5 North America Codeine Market by Country
      • 5.1.2.6 North America Morphine Market by Country
      • 5.1.2.7 North America Other Product Type Market by Country
    • 5.1.3 North America Opioids Market by Country
      • 5.1.3.1 US Opioids Market
        • 5.1.3.1.1 US Opioids Market by Application
        • 5.1.3.1.2 US Opioids Market by Product Type
      • 5.1.3.2 Canada Opioids Market
        • 5.1.3.2.1 Canada Opioids Market by Application
        • 5.1.3.2.2 Canada Opioids Market by Product Type
      • 5.1.3.3 Mexico Opioids Market
        • 5.1.3.3.1 Mexico Opioids Market by Application
        • 5.1.3.3.2 Mexico Opioids Market by Product Type
      • 5.1.3.4 Rest of North America Opioids Market
        • 5.1.3.4.1 Rest of North America Opioids Market by Application
        • 5.1.3.4.2 Rest of North America Opioids Market by Product Type
  • 5.2 Europe Opioids Market
    • 5.2.1 Europe Opioids Market by Application
      • 5.2.1.1 Europe Pain Management Market by Country
      • 5.2.1.2 Europe Cough Treatment Market by Country
      • 5.2.1.3 Europe Diarrhea Treatment Market by Country
    • 5.2.2 Europe Opioids Market by Product Type
      • 5.2.2.1 Europe Methadone Market by Country
      • 5.2.2.2 Europe Oxycodone Market by Country
      • 5.2.2.3 Europe Hydrocodone Market by Country
      • 5.2.2.4 Europe Fentanyl Market by Country
      • 5.2.2.5 Europe Codeine Market by Country
      • 5.2.2.6 Europe Morphine Market by Country
      • 5.2.2.7 Europe Other Product Type Market by Country
    • 5.2.3 Europe Opioids Market by Country
      • 5.2.3.1 Germany Opioids Market
        • 5.2.3.1.1 Germany Opioids Market by Application
        • 5.2.3.1.2 Germany Opioids Market by Product Type
      • 5.2.3.2 UK Opioids Market
        • 5.2.3.2.1 UK Opioids Market by Application
        • 5.2.3.2.2 UK Opioids Market by Product Type
      • 5.2.3.3 France Opioids Market
        • 5.2.3.3.1 France Opioids Market by Application
        • 5.2.3.3.2 France Opioids Market by Product Type
      • 5.2.3.4 Russia Opioids Market
        • 5.2.3.4.1 Russia Opioids Market by Application
        • 5.2.3.4.2 Russia Opioids Market by Product Type
      • 5.2.3.5 Spain Opioids Market
        • 5.2.3.5.1 Spain Opioids Market by Application
        • 5.2.3.5.2 Spain Opioids Market by Product Type
      • 5.2.3.6 Italy Opioids Market
        • 5.2.3.6.1 Italy Opioids Market by Application
        • 5.2.3.6.2 Italy Opioids Market by Product Type
      • 5.2.3.7 Rest of Europe Opioids Market
        • 5.2.3.7.1 Rest of Europe Opioids Market by Application
        • 5.2.3.7.2 Rest of Europe Opioids Market by Product Type
  • 5.3 Asia Pacific Opioids Market
    • 5.3.1 Asia Pacific Opioids Market by Application
      • 5.3.1.1 Asia Pacific Pain Management Market by Country
      • 5.3.1.2 Asia Pacific Cough Treatment Market by Country
      • 5.3.1.3 Asia Pacific Diarrhea Treatment Market by Country
    • 5.3.2 Asia Pacific Opioids Market by Product Type
      • 5.3.2.1 Asia Pacific Methadone Market by Country
      • 5.3.2.2 Asia Pacific Oxycodone Market by Country
      • 5.3.2.3 Asia Pacific Hydrocodone Market by Country
      • 5.3.2.4 Asia Pacific Fentanyl Market by Country
      • 5.3.2.5 Asia Pacific Codeine Market by Country
      • 5.3.2.6 Asia Pacific Morphine Market by Country
      • 5.3.2.7 Asia Pacific Other Product Type Market by Country
    • 5.3.3 Asia Pacific Opioids Market by Country
      • 5.3.3.1 China Opioids Market
        • 5.3.3.1.1 China Opioids Market by Application
        • 5.3.3.1.2 China Opioids Market by Product Type
      • 5.3.3.2 Japan Opioids Market
        • 5.3.3.2.1 Japan Opioids Market by Application
        • 5.3.3.2.2 Japan Opioids Market by Product Type
      • 5.3.3.3 India Opioids Market
        • 5.3.3.3.1 India Opioids Market by Application
        • 5.3.3.3.2 India Opioids Market by Product Type
      • 5.3.3.4 South Korea Opioids Market
        • 5.3.3.4.1 South Korea Opioids Market by Application
        • 5.3.3.4.2 South Korea Opioids Market by Product Type
      • 5.3.3.5 Singapore Opioids Market
        • 5.3.3.5.1 Singapore Opioids Market by Application
        • 5.3.3.5.2 Singapore Opioids Market by Product Type
      • 5.3.3.6 Malaysia Opioids Market
        • 5.3.3.6.1 Malaysia Opioids Market by Application
        • 5.3.3.6.2 Malaysia Opioids Market by Product Type
      • 5.3.3.7 Rest of Asia Pacific Opioids Market
        • 5.3.3.7.1 Rest of Asia Pacific Opioids Market by Application
        • 5.3.3.7.2 Rest of Asia Pacific Opioids Market by Product Type
  • 5.4 LAMEA Opioids Market
    • 5.4.1 LAMEA Opioids Market by Application
      • 5.4.1.1 LAMEA Pain Management Market by Country
      • 5.4.1.2 LAMEA Cough Treatment Market by Country
      • 5.4.1.3 LAMEA Diarrhea Treatment Market by Country
    • 5.4.2 LAMEA Opioids Market by Product Type
      • 5.4.2.1 LAMEA Methadone Market by Country
      • 5.4.2.2 LAMEA Oxycodone Market by Country
      • 5.4.2.3 LAMEA Hydrocodone Market by Country
      • 5.4.2.4 LAMEA Fentanyl Market by Country
      • 5.4.2.5 LAMEA Codeine Market by Country
      • 5.4.2.6 LAMEA Morphine Market by Country
      • 5.4.2.7 LAMEA Other Product Type Market by Country
    • 5.4.3 LAMEA Opioids Market by Country
      • 5.4.3.1 Brazil Opioids Market
        • 5.4.3.1.1 Brazil Opioids Market by Application
        • 5.4.3.1.2 Brazil Opioids Market by Product Type
      • 5.4.3.2 Argentina Opioids Market
        • 5.4.3.2.1 Argentina Opioids Market by Application
        • 5.4.3.2.2 Argentina Opioids Market by Product Type
      • 5.4.3.3 UAE Opioids Market
        • 5.4.3.3.1 UAE Opioids Market by Application
        • 5.4.3.3.2 UAE Opioids Market by Product Type
      • 5.4.3.4 Saudi Arabia Opioids Market
        • 5.4.3.4.1 Saudi Arabia Opioids Market by Application
        • 5.4.3.4.2 Saudi Arabia Opioids Market by Product Type
      • 5.4.3.5 South Africa Opioids Market
        • 5.4.3.5.1 South Africa Opioids Market by Application
        • 5.4.3.5.2 South Africa Opioids Market by Product Type
      • 5.4.3.6 Nigeria Opioids Market
        • 5.4.3.6.1 Nigeria Opioids Market by Application
        • 5.4.3.6.2 Nigeria Opioids Market by Product Type
      • 5.4.3.7 Rest of LAMEA Opioids Market
        • 5.4.3.7.1 Rest of LAMEA Opioids Market by Application
        • 5.4.3.7.2 Rest of LAMEA Opioids Market by Product Type

Chapter 6. Company Profiles

  • 6.1 Johnson and Johnson
    • 6.1.1 Company Overview
    • 6.1.2 Financial Analysis
    • 6.1.3 Segmental &Regional Analysis
    • 6.1.4 Research & Development Expenses
  • 6.2 AstraZeneca PLC
    • 6.2.1 Company Overview
    • 6.2.2 Financial Analysis
    • 6.2.3 Regional Analysis
    • 6.2.4 Research & Development Expenses
  • 6.3 Boehringer Ingelheim International Gmbh
    • 6.3.1 Company Overview
    • 6.3.2 Financial Analysis
    • 6.3.3 Regional & Segmental Analysis
    • 6.3.4 Research & Development Expenses
    • 6.3.5 Recent strategies and developments:
      • 6.3.5.1 Approvals and Trials:
  • 6.4 Endo International PLC
    • 6.4.1 Company Overview
    • 6.4.2 Financial Analysis
    • 6.4.3 Segmental Analysis
    • 6.4.4 Research & Development Expenses
  • 6.5 Mallinckrodt PLC
    • 6.5.1 Company Overview
    • 6.5.1 Financial Analysis
    • 6.5.2 Segmental and Regional Analysis
    • 6.5.3 Research & Development Expense
  • 6.6 Sanofi S.A.
    • 6.6.1 Company Overview
    • 6.6.2 Financial Analysis
    • 6.6.3 Segmental and Regional Analysis
    • 6.6.4 Research & Development Expense
    • 6.6.5 Recent strategies and developments:
      • 6.6.5.1 Acquisition and Mergers:
  • 6.7 Pfizer, Inc.
    • 6.7.1 Company Overview
    • 6.7.1 Financial Analysis
    • 6.7.2 Regional Analysis
    • 6.7.3 Research & Development Expense
    • 6.7.4 Recent strategies and developments:
      • 6.7.4.1 Approvals and Trials:
  • 6.8 Teva Pharmaceutical Industries Ltd.
    • 6.8.1 Company Overview
    • 6.8.2 Financial Analysis
    • 6.8.3 Regional Analysis
    • 6.8.4 Research & Development Expenses
    • 6.8.5 Recent strategies and developments:
      • 6.8.5.1 Product Launches and Product Expansions:
      • 6.8.5.2 Approvals and Trials:
  • 6.9 Sun Pharmaceutical Industries Ltd.
    • 6.9.1 Company Overview
    • 6.9.2 Financial Analysis
    • 6.9.3 Regional Analysis
    • 6.9.4 Research & Development Expense
  • 6.10. Purdue Pharma L.P.
    • 6.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 Global Opioids Market, 2017 - 2020, USD Million
  • TABLE 2 Global opioids Market, 2021 - 2027, USD Million
  • TABLE 3 Global Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 4 Global Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 5 Global Pain Management Market by Region, 2017 - 2020, USD Million
  • TABLE 6 Global Pain Management Market by Region, 2021 - 2027, USD Million
  • TABLE 7 Global Cough Treatment Market by Region, 2017 - 2020, USD Million
  • TABLE 8 Global Cough Treatment Market by Region, 2021 - 2027, USD Million
  • TABLE 9 Global Diarrhea Treatment Market by Region, 2017 - 2020, USD Million
  • TABLE 10 Global Diarrhea Treatment Market by Region, 2021 - 2027, USD Million
  • TABLE 11 Global Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 12 Global Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 13 Global Methadone Market by Region, 2017 - 2020, USD Million
  • TABLE 14 Global Methadone Market by Region, 2021 - 2027, USD Million
  • TABLE 15 Global Oxycodone Market by Region, 2017 - 2020, USD Million
  • TABLE 16 Global Oxycodone Market by Region, 2021 - 2027, USD Million
  • TABLE 17 Global Hydrocodone Market by Region, 2017 - 2020, USD Million
  • TABLE 18 Global Hydrocodone Market by Region, 2021 - 2027, USD Million
  • TABLE 19 Global Fentanyl Market by Region, 2017 - 2020, USD Million
  • TABLE 20 Global Fentanyl Market by Region, 2021 - 2027, USD Million
  • TABLE 21 Global Codeine Market by Region, 2017 - 2020, USD Million
  • TABLE 22 Global Codeine Market by Region, 2021 - 2027, USD Million
  • TABLE 23 Global Morphine Market by Region, 2017 - 2020, USD Million
  • TABLE 24 Global Morphine Market by Region, 2021 - 2027, USD Million
  • TABLE 25 Global Other Product Type Market by Region, 2017 - 2020, USD Million
  • TABLE 26 Global Other Product Type Market by Region, 2021 - 2027, USD Million
  • TABLE 27 Global Opioids Market by Region, 2017 - 2020, USD Million
  • TABLE 28 Global Opioids Market by Region, 2021 - 2027, USD Million
  • TABLE 29 North America Opioids Market, 2017 - 2020, USD Million
  • TABLE 30 North America Opioids Market, 2021 - 2027, USD Million
  • TABLE 31 North America Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 32 North America Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 33 North America Pain Management Market by Country, 2017 - 2020, USD Million
  • TABLE 34 North America Pain Management Market by Country, 2021 - 2027, USD Million
  • TABLE 35 North America Cough Treatment Market by Country, 2017 - 2020, USD Million
  • TABLE 36 North America Cough Treatment Market by Country, 2021 - 2027, USD Million
  • TABLE 37 North America Diarrhea Treatment Market by Country, 2017 - 2020, USD Million
  • TABLE 38 North America Diarrhea Treatment Market by Country, 2021 - 2027, USD Million
  • TABLE 39 North America Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 40 North America Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 41 North America Methadone Market by Country, 2017 - 2020, USD Million
  • TABLE 42 North America Methadone Market by Country, 2021 - 2027, USD Million
  • TABLE 43 North America Oxycodone Market by Country, 2017 - 2020, USD Million
  • TABLE 44 North America Oxycodone Market by Country, 2021 - 2027, USD Million
  • TABLE 45 North America Hydrocodone Market by Country, 2017 - 2020, USD Million
  • TABLE 46 North America Hydrocodone Market by Country, 2021 - 2027, USD Million
  • TABLE 47 North America Fentanyl Market by Country, 2017 - 2020, USD Million
  • TABLE 48 North America Fentanyl Market by Country, 2021 - 2027, USD Million
  • TABLE 49 North America Codeine Market by Country, 2017 - 2020, USD Million
  • TABLE 50 North America Codeine Market by Country, 2021 - 2027, USD Million
  • TABLE 51 North America Morphine Market by Country, 2017 - 2020, USD Million
  • TABLE 52 North America Morphine Market by Country, 2021 - 2027, USD Million
  • TABLE 53 North America Other Product Type Market by Country, 2017 - 2020, USD Million
  • TABLE 54 North America Other Product Type Market by Country, 2021 - 2027, USD Million
  • TABLE 55 North America Opioids Market by Country, 2017 - 2020, USD Million
  • TABLE 56 North America Opioids Market by Country, 2021 - 2027, USD Million
  • TABLE 57 US Opioids Market, 2017 - 2020, USD Million
  • TABLE 58 US Opioids Market, 2021 - 2027, USD Million
  • TABLE 59 US Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 60 US Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 61 US Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 62 US Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 63 Canada Opioids Market, 2017 - 2020, USD Million
  • TABLE 64 Canada Opioids Market, 2021 - 2027, USD Million
  • TABLE 65 Canada Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 66 Canada Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 67 Canada Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 68 Canada Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 69 Mexico Opioids Market, 2017 - 2020, USD Million
  • TABLE 70 Mexico Opioids Market, 2021 - 2027, USD Million
  • TABLE 71 Mexico Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 72 Mexico Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 73 Mexico Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 74 Mexico Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 75 Rest of North America Opioids Market, 2017 - 2020, USD Million
  • TABLE 76 Rest of North America Opioids Market, 2021 - 2027, USD Million
  • TABLE 77 Rest of North America Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 78 Rest of North America Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 79 Rest of North America Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 80 Rest of North America Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 81 Europe Opioids Market, 2017 - 2020, USD Million
  • TABLE 82 Europe Opioids Market, 2021 - 2027, USD Million
  • TABLE 83 Europe Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 84 Europe Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 85 Europe Pain Management Market by Country, 2017 - 2020, USD Million
  • TABLE 86 Europe Pain Management Market by Country, 2021 - 2027, USD Million
  • TABLE 87 Europe Cough Treatment Market by Country, 2017 - 2020, USD Million
  • TABLE 88 Europe Cough Treatment Market by Country, 2021 - 2027, USD Million
  • TABLE 89 Europe Diarrhea Treatment Market by Country, 2017 - 2020, USD Million
  • TABLE 90 Europe Diarrhea Treatment Market by Country, 2021 - 2027, USD Million
  • TABLE 91 Europe Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 92 Europe Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 93 Europe Methadone Market by Country, 2017 - 2020, USD Million
  • TABLE 94 Europe Methadone Market by Country, 2021 - 2027, USD Million
  • TABLE 95 Europe Oxycodone Market by Country, 2017 - 2020, USD Million
  • TABLE 96 Europe Oxycodone Market by Country, 2021 - 2027, USD Million
  • TABLE 97 Europe Hydrocodone Market by Country, 2017 - 2020, USD Million
  • TABLE 98 Europe Hydrocodone Market by Country, 2021 - 2027, USD Million
  • TABLE 99 Europe Fentanyl Market by Country, 2017 - 2020, USD Million
  • TABLE 100 Europe Fentanyl Market by Country, 2021 - 2027, USD Million
  • TABLE 101 Europe Codeine Market by Country, 2017 - 2020, USD Million
  • TABLE 102 Europe Codeine Market by Country, 2021 - 2027, USD Million
  • TABLE 103 Europe Morphine Market by Country, 2017 - 2020, USD Million
  • TABLE 104 Europe Morphine Market by Country, 2021 - 2027, USD Million
  • TABLE 105 Europe Other Product Type Market by Country, 2017 - 2020, USD Million
  • TABLE 106 Europe Other Product Type Market by Country, 2021 - 2027, USD Million
  • TABLE 107 Europe Opioids Market by Country, 2017 - 2020, USD Million
  • TABLE 108 Europe Opioids Market by Country, 2021 - 2027, USD Million
  • TABLE 109 Germany Opioids Market, 2017 - 2020, USD Million
  • TABLE 110 Germany Opioids Market, 2021 - 2027, USD Million
  • TABLE 111 Germany Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 112 Germany Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 113 Germany Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 114 Germany Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 115 UK Opioids Market, 2017 - 2020, USD Million
  • TABLE 116 UK Opioids Market, 2021 - 2027, USD Million
  • TABLE 117 UK Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 118 UK Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 119 UK Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 120 UK Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 121 France Opioids Market, 2017 - 2020, USD Million
  • TABLE 122 France Opioids Market, 2021 - 2027, USD Million
  • TABLE 123 France Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 124 France Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 125 France Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 126 France Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 127 Russia Opioids Market, 2017 - 2020, USD Million
  • TABLE 128 Russia Opioids Market, 2021 - 2027, USD Million
  • TABLE 129 Russia Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 130 Russia Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 131 Russia Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 132 Russia Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 133 Spain Opioids Market, 2017 - 2020, USD Million
  • TABLE 134 Spain Opioids Market, 2021 - 2027, USD Million
  • TABLE 135 Spain Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 136 Spain Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 137 Spain Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 138 Spain Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 139 Italy Opioids Market, 2017 - 2020, USD Million
  • TABLE 140 Italy Opioids Market, 2021 - 2027, USD Million
  • TABLE 141 Italy Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 142 Italy Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 143 Italy Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 144 Italy Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 145 Rest of Europe Opioids Market, 2017 - 2020, USD Million
  • TABLE 146 Rest of Europe Opioids Market, 2021 - 2027, USD Million
  • TABLE 147 Rest of Europe Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 148 Rest of Europe Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 149 Rest of Europe Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 150 Rest of Europe Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 151 Asia Pacific Opioids Market, 2017 - 2020, USD Million
  • TABLE 152 Asia Pacific Opioids Market, 2021 - 2027, USD Million
  • TABLE 153 Asia Pacific Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 154 Asia Pacific Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 155 Asia Pacific Pain Management Market by Country, 2017 - 2020, USD Million
  • TABLE 156 Asia Pacific Pain Management Market by Country, 2021 - 2027, USD Million
  • TABLE 157 Asia Pacific Cough Treatment Market by Country, 2017 - 2020, USD Million
  • TABLE 158 Asia Pacific Cough Treatment Market by Country, 2021 - 2027, USD Million
  • TABLE 159 Asia Pacific Diarrhea Treatment Market by Country, 2017 - 2020, USD Million
  • TABLE 160 Asia Pacific Diarrhea Treatment Market by Country, 2021 - 2027, USD Million
  • TABLE 161 Asia Pacific Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 162 Asia Pacific Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 163 Asia Pacific Methadone Market by Country, 2017 - 2020, USD Million
  • TABLE 164 Asia Pacific Methadone Market by Country, 2021 - 2027, USD Million
  • TABLE 165 Asia Pacific Oxycodone Market by Country, 2017 - 2020, USD Million
  • TABLE 166 Asia Pacific Oxycodone Market by Country, 2021 - 2027, USD Million
  • TABLE 167 Asia Pacific Hydrocodone Market by Country, 2017 - 2020, USD Million
  • TABLE 168 Asia Pacific Hydrocodone Market by Country, 2021 - 2027, USD Million
  • TABLE 169 Asia Pacific Fentanyl Market by Country, 2017 - 2020, USD Million
  • TABLE 170 Asia Pacific Fentanyl Market by Country, 2021 - 2027, USD Million
  • TABLE 171 Asia Pacific Codeine Market by Country, 2017 - 2020, USD Million
  • TABLE 172 Asia Pacific Codeine Market by Country, 2021 - 2027, USD Million
  • TABLE 173 Asia Pacific Morphine Market by Country, 2017 - 2020, USD Million
  • TABLE 174 Asia Pacific Morphine Market by Country, 2021 - 2027, USD Million
  • TABLE 175 Asia Pacific Other Product Type Market by Country, 2017 - 2020, USD Million
  • TABLE 176 Asia Pacific Other Product Type Market by Country, 2021 - 2027, USD Million
  • TABLE 177 Asia Pacific Opioids Market by Country, 2017 - 2020, USD Million
  • TABLE 178 Asia Pacific Opioids Market by Country, 2021 - 2027, USD Million
  • TABLE 179 China Opioids Market, 2017 - 2020, USD Million
  • TABLE 180 China Opioids Market, 2021 - 2027, USD Million
  • TABLE 181 China Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 182 China Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 183 China Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 184 China Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 185 Japan Opioids Market, 2017 - 2020, USD Million
  • TABLE 186 Japan Opioids Market, 2021 - 2027, USD Million
  • TABLE 187 Japan Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 188 Japan Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 189 Japan Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 190 Japan Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 191 India Opioids Market, 2017 - 2020, USD Million
  • TABLE 192 India Opioids Market, 2021 - 2027, USD Million
  • TABLE 193 India Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 194 India Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 195 India Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 196 India Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 197 South Korea Opioids Market, 2017 - 2020, USD Million
  • TABLE 198 South Korea Opioids Market, 2021 - 2027, USD Million
  • TABLE 199 South Korea Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 200 South Korea Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 201 South Korea Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 202 South Korea Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 203 Singapore Opioids Market, 2017 - 2020, USD Million
  • TABLE 204 Singapore Opioids Market, 2021 - 2027, USD Million
  • TABLE 205 Singapore Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 206 Singapore Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 207 Singapore Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 208 Singapore Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 209 Malaysia Opioids Market, 2017 - 2020, USD Million
  • TABLE 210 Malaysia Opioids Market, 2021 - 2027, USD Million
  • TABLE 211 Malaysia Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 212 Malaysia Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 213 Malaysia Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 214 Malaysia Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 215 Rest of Asia Pacific Opioids Market, 2017 - 2020, USD Million
  • TABLE 216 Rest of Asia Pacific Opioids Market, 2021 - 2027, USD Million
  • TABLE 217 Rest of Asia Pacific Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 218 Rest of Asia Pacific Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 219 Rest of Asia Pacific Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 220 Rest of Asia Pacific Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 221 LAMEA Opioids Market, 2017 - 2020, USD Million
  • TABLE 222 LAMEA Opioids Market, 2021 - 2027, USD Million
  • TABLE 223 LAMEA Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 224 LAMEA Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 225 LAMEA Pain Management Market by Country, 2017 - 2020, USD Million
  • TABLE 226 LAMEA Pain Management Market by Country, 2021 - 2027, USD Million
  • TABLE 227 LAMEA Cough Treatment Market by Country, 2017 - 2020, USD Million
  • TABLE 228 LAMEA Cough Treatment Market by Country, 2021 - 2027, USD Million
  • TABLE 229 LAMEA Diarrhea Treatment Market by Country, 2017 - 2020, USD Million
  • TABLE 230 LAMEA Diarrhea Treatment Market by Country, 2021 - 2027, USD Million
  • TABLE 231 LAMEA Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 232 LAMEA Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 233 LAMEA Methadone Market by Country, 2017 - 2020, USD Million
  • TABLE 234 LAMEA Methadone Market by Country, 2021 - 2027, USD Million
  • TABLE 235 LAMEA Oxycodone Market by Country, 2017 - 2020, USD Million
  • TABLE 236 LAMEA Oxycodone Market by Country, 2021 - 2027, USD Million
  • TABLE 237 LAMEA Hydrocodone Market by Country, 2017 - 2020, USD Million
  • TABLE 238 LAMEA Hydrocodone Market by Country, 2021 - 2027, USD Million
  • TABLE 239 LAMEA Fentanyl Market by Country, 2017 - 2020, USD Million
  • TABLE 240 LAMEA Fentanyl Market by Country, 2021 - 2027, USD Million
  • TABLE 241 LAMEA Codeine Market by Country, 2017 - 2020, USD Million
  • TABLE 242 LAMEA Codeine Market by Country, 2021 - 2027, USD Million
  • TABLE 243 LAMEA Morphine Market by Country, 2017 - 2020, USD Million
  • TABLE 244 LAMEA Morphine Market by Country, 2021 - 2027, USD Million
  • TABLE 245 LAMEA Other Product Type Market by Country, 2017 - 2020, USD Million
  • TABLE 246 LAMEA Other Product Type Market by Country, 2021 - 2027, USD Million
  • TABLE 247 LAMEA Opioids Market by Country, 2017 - 2020, USD Million
  • TABLE 248 LAMEA Opioids Market by Country, 2021 - 2027, USD Million
  • TABLE 249 Brazil Opioids Market, 2017 - 2020, USD Million
  • TABLE 250 Brazil Opioids Market, 2021 - 2027, USD Million
  • TABLE 251 Brazil Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 252 Brazil Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 253 Brazil Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 254 Brazil Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 255 Argentina Opioids Market, 2017 - 2020, USD Million
  • TABLE 256 Argentina Opioids Market, 2021 - 2027, USD Million
  • TABLE 257 Argentina Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 258 Argentina Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 259 Argentina Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 260 Argentina Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 261 UAE Opioids Market, 2017 - 2020, USD Million
  • TABLE 262 UAE Opioids Market, 2021 - 2027, USD Million
  • TABLE 263 UAE Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 264 UAE Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 265 UAE Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 266 UAE Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 267 Saudi Arabia Opioids Market, 2017 - 2020, USD Million
  • TABLE 268 Saudi Arabia Opioids Market, 2021 - 2027, USD Million
  • TABLE 269 Saudi Arabia Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 270 Saudi Arabia Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 271 Saudi Arabia Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 272 Saudi Arabia Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 273 South Africa Opioids Market, 2017 - 2020, USD Million
  • TABLE 274 South Africa Opioids Market, 2021 - 2027, USD Million
  • TABLE 275 South Africa Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 276 South Africa Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 277 South Africa Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 278 South Africa Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 279 Nigeria Opioids Market, 2017 - 2020, USD Million
  • TABLE 280 Nigeria Opioids Market, 2021 - 2027, USD Million
  • TABLE 281 Nigeria Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 282 Nigeria Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 283 Nigeria Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 284 Nigeria Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 285 Rest of LAMEA Opioids Market, 2017 - 2020, USD Million
  • TABLE 286 Rest of LAMEA Opioids Market, 2021 - 2027, USD Million
  • TABLE 287 Rest of LAMEA Opioids Market by Application, 2017 - 2020, USD Million
  • TABLE 288 Rest of LAMEA Opioids Market by Application, 2021 - 2027, USD Million
  • TABLE 289 Rest of LAMEA Opioids Market by Product Type, 2017 - 2020, USD Million
  • TABLE 290 Rest of LAMEA Opioids Market by Product Type, 2021 - 2027, USD Million
  • TABLE 291 Key information -Johnson and Johnson
  • TABLE 292 Key Information - AstraZeneca PLC
  • TABLE 293 Key Information - Boehringer Ingelheim International GmbH
  • TABLE 294 key Information - Endo International PLC
  • TABLE 295 Key information - Mallinckrodt PLC
  • TABLE 296 Key Information - Sanofi S.A.
  • TABLE 297 Key Information - Pfizer, Inc.
  • TABLE 298 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 299 Key Information - Sun Pharmaceutical Industries Ltd.
  • TABLE 300 Key Information - Purdue Pharma L.P.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Opioids Market share by Application, 2020
  • FIG 3 Global Opioids Market share by Application, 2027
  • FIG 4 Global Opioids Market by Application, 2017 - 2027, USD Million
  • FIG 5 Global Opioids Market share by Product Type, 2020
  • FIG 6 Global Opioids Market share by Product Type, 2027
  • FIG 7 Global Opioids Market by Product Type, 2017 - 2027, USD Million
  • FIG 8 Global Opioids Market by Region, 2020
  • FIG 9 Global Opioids Market by Region, 2027
  • FIG 10 Global Opioids Market by Region, 2017 - 2027, USD Million
  • FIG 11 Recent strategies and developments: Teva Pharmaceuticals Industries Ltd.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!